Source: FierceBiotech St. Jude Medical released new data from a trial that showed patients using its CardioMEMS HF system had…...
Latest News
Business deaths are hampering job growth
Source: Gallup Small businesses and startups are the crux of economic growth in the United States. Gallup continually collects and…...
Actavis beats on top and bottom lines, will change name to Allergan
Source: The Street NEW YORK -- Specialty pharmaceutical company Actavis (ACT) reported fourth-quarter and full-year earnings results Wednesday that beat…...
Hiring in 2015? 5 trends to prepare for
Source: Business News Daily If you're looking for a new job, you should have better luck finding one this year,…...
Why great managers are so rare
Source: Gallup Management talent exists in every company. It's often hiding in plain sight. Gallup has found that one of…...
Court ruling against FDA enables more combination products to be classified as devices
Source: FierceBiotech In victory for industry, FDA's second attempt to classify Prevor's skin wash as a device is vacated once…...
AbbVie partners with Google’s Calico on $1.5B R&D operation focused on aging
Source: FierceBiotech Hot on the heels of its $805 million development deal with Infinity, AbbVie Pharmaceuticals ($ABBV) has followed up…...
Big Pharma doesn’t win the margin stakes. That’s Jazz, Celgene, Regeneron and Alexion
Source: Margins, margins, margins. That's an inevitable mantra among top investors and analysts. Just ask Novartis ($NVS) CEO Joe Jimenez,…...
Cubist Pharmaceuticals: Ripe For Acquisition?
Source: Bidness ETC Threats from the increase in drug-resistant germs, and the subsequent rise in demand for more effective and…...
After a 6-year delay, Medicines Co. bags FDA approval for once-troubled antibiotic
Source: FierceBiotech More than 5 years after The Medicines Company ($MDCO) bagged Targanta and its troubled antibiotic oritavancin for the…...